FindTrial
Sign In

Spinal bupivacaine heavy (0.5%) versus spinal ropivacaine heavy (0.75%) in orthopaedic surgery among elderly patients.

Intrathecal hyperbaric Bupivacaine 0.5% versus intrathecal hyperbaric Ropivacaine 0.75% in lower limb Orthopaedic surgery in elderly population-a comparative randomized single centre double blind study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044026
Enrollment
80
Registered
2022-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified

Interventions

Intervention1: Intrathecal injection Ropivacaine heavy: Intrathecal injection with Ropivacaine heavy (0.75%), 3 ml and with injection fentanyl citrate 0.5 ml at L4-L5 or L3-L4 level at sitting posture

Sponsors

Dr Swati Datta
Lead Sponsor
Dr Asim Kumar Kundu
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient scheduled for lower limb orthopedic surgery with ASA-PS I, II, III 2. Age > 65 years. 3. Able to understand VAS for pain assessment. 4. No H/o allergy to any drug of the study.

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Patients undergoing emergency surgery 3. Patients with bleeding disorder or local infection 4. Visible spinal deformity 5. Patients with severe medical complications

Design outcomes

Primary

MeasureTime frame
Sensory block assessment evaluated with visual analogue scale and sensory dermatomal anaesthesiaTimepoint: Three months (12 weeks) from the beginning of the study.—

Secondary

MeasureTime frame
Motor block assessmentTimepoint: 10 minutes after spinal anaesthesia is finished.—

Countries

India

Contacts

Public ContactSwati Datta

Medical College, Kolkata

drslahiri11@gmail.com09836979351

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026